2-Benzyloxy Atorvastatin Acetonide
|
- $165 - $504.56
- Product name: 2-Benzyloxy Atorvastatin Acetonide
- CAS: 1246820-45-0
- MF: C43H45FN2O6
- MW: 704.83
- EINECS:
- MDL Number:
- Synonyms:2-Benzyloxy Atorvastatin Acetonide;(4R,6R)-6-[2-[2-(4-Fluorophenyl)-5-(1-Methylethyl)-3-phenyl-4-[(2-benzyloxyphenylaMino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-diMethyl-1,3-dioxane-4-acetic Acid;1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[[[2-(phenylmethoxy)phenyl]amino]carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, (4R,6R)-rel-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- TRC
- Usbiological
Package
- 1mg
- 5MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberMTB0001860
- Product description2-BENZYLOXY ATORVASTATIN ACETONIDE 95.00%
- Packaging5MG
- Price$504.56
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB286155
- Product description2-BenzyloxyAtorvastatinAcetonide
- Packaging1mg
- Price$165
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number003697
- Product description2-Benzyloxy Atorvastatin Acetonide
- Packaging1mg
- Price$502
- Updated2026-06-03
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | MTB0001860 | 2-BENZYLOXY ATORVASTATIN ACETONIDE 95.00% | 5MG | $504.56 | 2021-12-16 | Buy |
| TRC | B286155 | 2-BenzyloxyAtorvastatinAcetonide | 1mg | $165 | 2021-12-16 | Buy |
| Usbiological | 003697 | 2-Benzyloxy Atorvastatin Acetonide | 1mg | $502 | 2026-06-03 | Buy |
Properties
Boiling point :778.2±60.0 °C(Predicted)
Density :1.20±0.1 g/cm3(Predicted)
solubility :Chloroform, Methanol
form :Solid
pka :4.24±0.10(Predicted)
color :White
Density :1.20±0.1 g/cm3(Predicted)
solubility :Chloroform, Methanol
form :Solid
pka :4.24±0.10(Predicted)
color :White
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




